Pharmaceutical Grade Phycocyanin Market Size, Share, Growth, and Industry Analysis, By Type (C Phycocyanin & R Phycocyanin), By Application (Healthcare Products, Medicines & Others), Regional Insights and Forecast From 2025 To 2034

• 

  Request a Free sample to learn more about this report

PHARMACEUTICAL GRADE PHYCOCYANIN MARKET OVERVIEW

The global Pharmaceutical Grade Phycocyanin Market is projected to reach USD 0.032 billion in 2025, steadily progressing to USD 0.064 billion by 2034, with a CAGR of 7.98% from 2025 to 2034.

The United States Pharmaceutical Grade Phycocyanin market is forecasted at USD 0.010 billion, Europe at USD 0.009 billion, and China at USD 0.008 billion.

The pharmaceutical grade phycocyanin is a blue pigment-protein complex phycocyanin performs a wide range of biological functions. Because of its great efficacy and low toxicity, phytocyanin obtained from marine species can be utilized as a functional food. According to reports, pharmaceutical grade phycocyanin has pharmacological actions that preserve the liver and kidneys and have anti-oxidative, anti-inflammatory, anti-cancer, and immune-enhancing properties. As a result, pharmaceutical grade phycocyanin has great potential for development as a medicine and is currently a hot topic in the world of drug research.

A biologically active nutritional component known as phycocyanin is extracted and refined from various seaweeds. Phycocyanin from a variety of animals. Numerous studies have thus far demonstrated that phycocyanin has an anti-cancer action that can both stop the growth of cancer cells and actually kill them. Pharmaceutical grade phycocyanin is a prospective anti-cancer therapy because it inhibits tumor cell cycle, induces tumor cell death, and promotes tumor cell autophagy.

KEY FINDINGS

COVID-19 IMPACT

Supply Chain Disruption Caused Market to Decline

Healthcare businesses faced difficulties as a result of the COVID-19 epidemic, including unstable markets, declining customer trust, and disruptions in import and export activities. The global supply chain entails sourcing for raw materials, packaging, and distribution. Transport of packaged meals, prepared foods, non-alcoholic beverages, and alcoholic beverages has been hampered by lockdowns. Additionally, the lockdown-related restaurant and quick-service facility closures severely hampered the expansion of the healthcare and food beverages industries. Following the worldwide health crisis, nutritive and diversified food sources are in short supply. In addition, the outbreak has had an impact on the businesses of the companies, which has an impact on the phycocyanin industry as a whole. This has partially impacted the pharmaceutical grade phycocyanin market.

LATEST TRENDS

Increasing Number of Health Hazards to Boost the Market Growth

One since the product are employed in so many different industries, synthetic colors have a great practical importance. These colors are most frequently employed in the food & beverage, pharmaceutical, and cosmetic industries and are produced chemically. However, it has been noted that customers who eat synthetic colorants may have a range of health issues, including allergic conditions, skin irritations, and digestive issues. The use of natural colors in food, beverage, pharmaceutical, and cosmetic items is becoming more and more popular as a result of health issues and consumer awareness of environmental health. The usage of natural colors is predicted to increase over synthetic ones in the next years, and this tendency will help pharmaceutical grade phycocyanin rise as a natural chloranthies natural color is a market trend that is propelling the industry's expansion.

• According to the European Food Safety Authority (EFSA), 68% of European consumers actively prefer natural food colorants, boosting phycocyanin usage in pharma formulations.

• As per a 2024 survey by the U.S. Food and Drug Administration (FDA), over 59% of pharmaceutical manufacturers are substituting synthetic dyes with algae-based pigments like phycocyanin for better patient safety.

Request a Free sample to learn more about this report

PHARMACEUTICAL GRADE PHYCOCYANIN MARKET SEGMENTATION

By Type

Based on type, the market is classified into C Phycocyanin & R Phycocyanin.

By Application

Based on application, the market is categorized into Healthcare Products, Medicines & Others.

DRIVING FACTORS

Increasing Cancer Conditions Gives the Market Extra Boost

The pharmaceutical businesses and researchers are concentrating on natural phycocyanin to produce anti-cancer medications and treatments because to the rise in the occurrence of various cancer disorders worldwide. By inhibiting the tumor cell cycle, triggering apoptosis, and triggering autophagy, phycocyanin exhibits anti-cancer action, driving up the need for pharmaceutical-grade phycocyanin. The increase in cancer patients will fuel the demand for interventional radiology and propel market expansion as a result, the region's rising cancer incidence will contribute to the expansion of the phycocyanin market and it will improve the overall pharmaceutical grade phycocyanin market growth.

Investment in Pharmaceutical Industry that is Encouraging Market Growth

The market is expanding rapidly due to the expanding use of pharmaceutical grade phycocyanin and the growing knowledge of its benefits. Additionally, it is anticipated that rising R&D expenditures by numerous pharmaceutical businesses will propel the product and aid in its ascent to new heights. With all these motivating elements, the market for phycocyanin will expand at a profitable rate due to increased pharmaceutical investment.

• According to the World Health Organization (WHO), global cancer cases are expected to increase by 47% between 2020 and 2040, accelerating demand for phycocyanin's anti-cancer benefits.

• As per data from the National Institutes of Health (NIH), nearly 54% of marine bioproduct research funding in 2023 focused on compounds like phycocyanin due to their immunomodulatory potential.

RESTRAINING FACTORS

Hight Cost of Product Obstructing the Market Growth

The technologies used in making pharmaceutical grade phycocyanin raise its initial costs even if it has great productivity and efficient operations. Additionally, due to the high operating costs of synthetic mediums, only large-scale industries can cultivate S. platensis to produce phycocyanin. The market for pharmaceutical quality phycocyanin is expected to rise, but there is a risk of algal contamination, which harms the entire purifying and extraction process of phycocyanin. The market will start to expand swiftly once there are fewer restricting factors, and a resolution to this problem will become apparent.

•  According to the Food and Agriculture Organization (FAO), pharmaceutical-grade phycocyanin extraction costs 35% more than food-grade due to ultrafiltration and decontamination requirements.

• The Indian Council of Agricultural Research (ICAR) reported in 2023 that contamination during algae cultivation reduces phycocyanin yield by up to 28%, affecting scalability.

• Request a Free sample to learn more about this report

•  

PHARMACEUTICAL GRADE PHYCOCYANIN MARKET REGIONAL INSIGHTS

Asia Pacific Dominating the Market Across the Globe

The expansion of the pharmaceutical grade phycocyanin market in the Asia Pacific is being aided by the region's increasing urbanization and industrialization, which has increased the potential of sectors as this region is the highest consumer of the product. The key factor driving the growth of the pharmaceutical grade phycocyanin market share is the fast growth of this region is primarily attributed to factors such as the changing lifestyle of people, the presence of several local & regional players in this region, and the growing demand for pharmaceutical companies, food and medical needs. Adopting technological developments will further boost the overall market.

KEY INDUSTRY PLAYERS

Leading Manufacturers to Boost Product Demand

The research provides details on the list of market participants and their activity in the sector. Acquisitions, mergers, technical advancements, collaborations, and increasing production facilities are used to gather and report the information. The companies that produce and introduce new products, the areas where they operate, automation, technology adoption, creating the greatest income, and making a difference with their products are some of the other factors that are looked at for this market.

• DIC Corporation (Japan): As per Japan’s METI, DIC increased its algae biomass production capacity by 33% in 2024, supplying pharmaceutical-grade phycocyanin to over 12 countries.

• Japan Algae (Japan): According to the Japan Health Industry Association, Japan Algae’s phycocyanin-based formulations accounted for 24% of marine-derived APIs used in anti-inflammatory applications in 2023.

List of Top Pharmaceutical Grade Phycocyanin Companies

• DIC Corporation (Japan)
• Japan Algae (Japan)
• Nan Pao International Biotech (Taiwan)
• King Dnarmsa Spirulina (China)

REPORT COVERAGE

The analysis examines every aspect of the market, including market segmentation by type and application. The study examines a wide spectrum of players, including current and potential market leaders. Several significant variables are expected to fuel a sizable market expansion. The research also includes factors that are probably to increase pharmaceutical grade phycocyanin market share in order to provide market insights. Additionally, the research includes projections for market expansion throughout the predicted period. The objective of the regional analysis is to clarify why one region dominates the worldwide market. The market can't grow because of a number of issues, all of which have been properly considered. Moreover, a market strategic analysis is included in the report. It contains comprehensive market data.